Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1034 | 1035 | (Page 1036) | 1037 | 1038 | .... | 1118 | newer

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Active Pharmaceutical Ingredient Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-active-pharmaceutical-ingredient-sales-market-report-2018
    Global Active Pharmaceutical Ingredient Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Teva
    • Novartis
    • Pfizer
    • Johnson & Johnson
    • Mylan
    • North China Pharmaceutical Group
    • Dr. Reddy’s Laboratories
    • Roche
    • Aurobindo Pharma
    • Sun Pharmaceutical Industries
    • Boehringer Ingelheim Gmbh
    • Bayer
    • BASF
    • DSM
    • Zhejiang Medicine
    • Biocon
    • Johnson Matthey
    • Hisun Pharmacy
    • Cambrex
    • Shandong Xinhua Pharmaceutical
    • Lonza Group
    • Huahai Pharmaceutical
    • Haerbin Pharmaceutical Group
    • Cipla
    • Tian Yao
    • Lupin
    • North East Pharmaceutical
    • Albemarle
    • Shandong Lukang Pharmaceutical
    • Jiangsu Hengrui Medicine
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/867759
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Synthetic API
    • Biotech API
    • Other
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Active Pharmaceutical Ingredient Sales for each application, including
    • Chemical
    • Deodorant
    • Dailylife
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/867759


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Axillary Hyperhidrosis Drug Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-axillary-hyperhidrosis-drug-sales-market-report-2018
    Global Axillary Hyperhidrosis Drug Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Allergan Plc
    • Brickell Biotech Inc
    • Dermira Inc
    • Dr. August Wolff Gmbh & Co Kg Arzneimittle
    • Glaxosmithkline Plc
    • Theravida Inc
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1117411
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Botulinum ToxinA
    • Glycopyrrolate
    • Glycopyrronium Tosylate
    • Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Axillary Hyperhidrosis Drug Sales for each application, including
    • Clinic
    • Hospital
    • Home Care
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1117411



    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Body Reconstruction Product Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-body-reconstruction-product-sales-market-report-2018
    Global Body Reconstruction Product Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Arthrex(US)
    • Smith & Nephew (UK)
    • Depuy Synthes (US)
    • Stryker (US)
    • CONMED (US)
    • Zimmer Biomet (US)
    • Breg (US)
    • DJO Global(US)
    • Mueller Sports (US)
    • Wright Medical Group (US)
    • Medtronic (Ireland)
    • RTI Surgical (US)
    • Performance Health International (US)
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1117417
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Implants
    • Fracture and Ligament Repair Devices
    • Arthroscopy Devices
    • Prosthetic Devices
    • Orthobiologics
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Body Reconstruction Product Sales for each application, including
    • Shoulder Injuries
    • Ankle & Foot Injuries
    • Elbow & Wrist Injuries
    • Back & Spine Injuries
    • Hip & Groin Injuries
    • Knee Injuries
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1117417


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cancer Gene Therapy Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-cancer-gene-therapy-sales-market-report-2018
    Global Cancer Gene Therapy Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Adaptimmune
    • Glaxosmithkline
    • Bluebird Bio
    • Merck
    • Celgene
    • Shanghai Sunway Biotech
    • Biocancell
    • Shenzhen Sibiono Genetech
    • Synergene Therapeutics
    • Oncogenex Pharmaceuticals
    • Genelux Corporation
    • Cell Genesys
    • Advantagene
    • Genvec
    • Biocancell
    • Celgene
    • Epeius Biotechnologies
    • Introgen Therapeutics
    • Ziopharm Oncology
    • Shenzhen Sibiono Genetech
    • Altor Bioscience
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1117423
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Gene Induced Immunotherapy
    • Oncolytic Virotherapy
    • Gene Transfer
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Cancer Gene Therapy Sales for each application, including
    • Hospitals
    • Diagnostics Centers
    • Research Institutes
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1117423


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cow Milk Infant Formula Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-cow-milk-infant-formula-sales-market-report-2018
    Global Cow Milk Infant Formula Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Nestle
    • Danone
    • Abbott
    • Frieslandcampina
    • Heinz
    • Bellamy
    • Topfer
    • Hipp
    • Perrigo
    • Arla
    • Holle
    • Fonterra
    • Westland Dairy
    • Pinnacle
    • Meiji
    • Yili
    • Biostime
    • Yashili
    • Feihe
    • Brightdairy
    • Beingmate
    • Wonderson
    • Synutra
    • Wissuns
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/870373
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Regular Infant Formula
    • Specialty Infant Formula
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Cow Milk Infant Formula Sales for each application, including
    • 0-6 Months Baby
    • 6-12 Months Baby
    • 12-36 Months Baby
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/870373


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hydrocephalus Shunts Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-hydrocephalus-shunts-sales-market-report-2018
    Global Hydrocephalus Shunts Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Medtronic
    • Johnson & Johnson
    • Integra Lifesciences
    • SOPHYSA
    • B.BRAUN
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/870441
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • Adjustable Valves
    • Monopressure Valves
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Hydrocephalus Shunts Sales for each application, including
    • Adult
    • Kids
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/870441


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 14, 2018 ) Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Mitogen Activated Protein Kinase 1 Sales in these regions, from 2013 to 2025 (forecast), covering
    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India
    Access Report Details at: https://www.themarketreports.com/report/global-mitogen-activated-protein-kinase-1-sales-market-report-2018
    Global Mitogen Activated Protein Kinase 1 Sales market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    • Aeterna Zentaris Inc.
    • Agv Discovery, Sas
    • Asana Biosciences, Llc
    • Genentech, Inc.
    • Kura Oncology, Inc.
    • Laurent Pharmaceuticals Inc.
    • Merck & Co., Inc.
    • Merck Kgaa
    Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/1117548
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    • CB-745
    • JRP-890
    • KO-947
    • LY-3214996
    • Others
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Mitogen Activated Protein Kinase 1 Sales for each application, including
    • Pancreatic Ductal Adenocarcinoma
    • Solid Tumor
    • Colon Cancer
    • Breast Cancer
    • Others
    Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/1117548


    Shirish Gupta
    +1-631-407-1315
    web@themarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT1D Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1D Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht1d-agonist-pipeline-insight-2018/2593560

    Descriptive coverage of pipeline development activities for “5-HT1D Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT1D Agonist

    The report assesses the active 5-HT1D Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/2593560 

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/2593560

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT1D Agonist
    Features the 5-HT1D Agonist pipeline across the complete product development cycle including all clinical and non-clinical stages
    Offers detailed therapeutic product profiles of 5-HT1D Agonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information
    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    Coverage of dormant and discontinued pipeline projects across “5-HT1D Agonist

    Discount before buying @ https://www.researchcosmos.com/discount/2593560

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT1D Agonist to formulate effective R&D strategies
    Assess challenges and opportunities that influence 5-HT1D Agonist research & development (R&D)
    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    Identify and understand the sought after therapy areas and indications for “5-HT1D Agonist
    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT1D Agonist to enhance and expand business potential and scope
    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress
    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT1A Antagonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht1a-antagonist-pipeline-insight-2018/7315951

    Descriptive coverage of pipeline development activities for “5-HT1A Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT1A Antagonist

    The report assesses the active 5-HT1A Antagonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/7315951

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/7315951

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT1A Antagonist

    Features the 5-HT1A Antagonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of 5-HT1A Antagonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “5-HT1A Antagonist

    Discount before buying @ https://www.researchcosmos.com/discount/7315951

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT1A Antagonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence 5-HT1A Antagonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

     Identify and understand the sought after therapy areas and indications for “5-HT1A Antagonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT1A Antagonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 )

    Description:

    This report studies End Stage Kidney Disease Treatment In Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    BLR Bio LLC
    CTI BioPharma Corp
    F. HoffmannLa Roche Ltd
    Novartis AG
    Prolong Pharmaceuticals LLC
    VESSL Therapeutics Ltd
    ...

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/global-endstage-kidney-disease-treatment-market-5822

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    MK3866
    Pacritinib
    Sanguinate
    Tesidolumab
    Others

    By Application, the market can be split into
    Clinic
    Hospital
    Others

    By Regions, this report covers we can add the regions/countries as you want
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

    Get Free Sample of this Report @ https://www.planetmarketreports.com/report-sample/global-endstage-kidney-disease-treatment-market-5822

    Table of Contents

    Global End-Stage Kidney Disease Treatment Market Professional Survey Report 2018
    1 Industry Overview of End-Stage Kidney Disease Treatment
    1.1 Definition and Specifications of End-Stage Kidney Disease Treatment
    1.1.1 Definition of End-Stage Kidney Disease Treatment
    1.1.2 Specifications of End-Stage Kidney Disease Treatment
    1.2 Classification of End-Stage Kidney Disease Treatment
    1.2.1 MK3866
    1.2.2 Pacritinib
    1.2.3 Sanguinate
    1.2.4 Tesidolumab
    1.2.5 Others
    1.3 Applications of End-Stage Kidney Disease Treatment

    2 Manufacturing Cost Structure Analysis of End-Stage Kidney Disease Treatment
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of End-Stage Kidney Disease Treatment

    3 Technical Data and Manufacturing Plants Analysis of End-Stage Kidney Disease Treatment
    3.1 Capacity and Commercial Production Date of Global End-Stage Kidney Disease Treatment Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global End-Stage Kidney Disease Treatment Major Manufacturers in 2017

    4 Global End-Stage Kidney Disease Treatment Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis

    5 End-Stage Kidney Disease Treatment Regional Market Analysis
    5.1 North America End-Stage Kidney Disease Treatment Market Analysis
    5.1.1 North America End-Stage Kidney Disease Treatment Market Overview

    Read more…..!!!!!

    To Browse Similar Reports @ https://www.planetmarketreports.com/category/pharmaceutical-and-healthcare

    About Us:-

    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe.  We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

    Contact Us:-

    Name: Ronald James

    Email-Id: ronald.james@planetmarketreports.com

    US: +1-716-2260907

    UK: +447441952057

    Organization: Planet Market Reports

    Website: https://www.planetmarketreports.com/


    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT1B Antagonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht1b-antagonist-pipeline-insight-2018/3220310

    Descriptive coverage of pipeline development activities for “5-HT1B Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT1B Antagonist

    The report assesses the active 5-HT1B Antagonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/3220310

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/3220310   

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT1B Antagonist
    Features the 5-HT1B Antagonist pipeline across the complete product development cycle including all clinical and non-clinical stages
    Offers detailed therapeutic product profiles of 5-HT1B Antagonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information
    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    Coverage of dormant and discontinued pipeline projects across “5-HT1B Antagonist

    Discount before buying @ https://www.researchcosmos.com/discount/3220310

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT1B Antagonist to formulate effective R&D strategies
    Assess challenges and opportunities that influence 5-HT1B Antagonist research & development (R&D)
    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    Identify and understand the sought after therapy areas and indications for “5-HT1B Antagonist
    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT1B Antagonist to enhance and expand business potential and scope
    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress
    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT1B Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT1B Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht1b-agonist-pipeline-insight-2018/5768005

    Descriptive coverage of pipeline development activities for “5-HT1B Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT1B Agonist

    The report assesses the active 5-HT1B Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Request free sample @ https://www.researchcosmos.com/request/5768005

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT1B Agonist

    Features the 5-HT1B Agonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of 5-HT1B Agonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “5-HT1B Agonist

    Inquire before buying @ https://www.researchcosmos.com/inquire/5768005

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT1B Agonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence 5-HT1B Agonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “5-HT1B Agonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT1B Agonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 15, 2018 ) Singapore: A global report titled  Ostomy Products Market has been introduced into our library of 2.5 million reports.

    About the market report:
    An ostomy is a surgical procedure that is performed to create an opening in the abdomen to excrete the waste products. Such surgical openings in the abdomen are known as artificial stoma. Based on the complications, artificial stomas can be temporary or permanent. People who undergo temporary ostomy procedure also undergo therapeutic procedures, which help to recover the intestine. In such cases, stomas can be reversed. In both temporary and permanent ostomy procedures, ostomy bags are attached to the stoma to collect the waste products. To enhance the performance and increase the comfort level, ostomy accessories are used, which help to prevent leakage, prevent infection and skin rashes, and reduce the odor of wastes in the ostomy bags. 

    To access the full table of contents of the report click below:
    https://www.marketintelreports.com/report/tech1548/global-ostomy-products-market-20182022

    Scope of the Report:
    This report focuses on theOstomy Products Board in global market, especially in Americas, APAC,EMEA.This report categorizes the market based on manufacturers, regions, types and applications.

    Sample companies covered are ALCARE, B. Braun Melsungen, Coloplast, ConvaTec,

    To find out more of the report or request some customization : https://www.marketintelreports.com/inquiry-before-buying.php?id=tech1548

    Table of Contents-Key Points Covered
    PART 01: EXECUTIVE SUMMARY
    PART 02: SCOPE OF THE REPORT
    PART 03: RESEARCH METHODOLOGY
    PART 04: INTRODUCTION
    • Market outline
    • Types of Ostomy Products and its segmentation
    PART 05: MARKET LANDSCAPE
    • Market ecosystem
    • Market characteristics
    • Market segmentation analysis
    ………….
    PART 09: CUSTOMER LANDSCAPE
    PART 10: MARKET SEGMENTATION BY END-USERS
    • Segmentation by end-users
    • Healthcare settings
    • Retail stores
    • Home-care settings
    PART 11: REGIONAL LANDSCAPE
    • Geographical segmentation
    • Regional comparison
    • Ostomy products market in Americas
    • Ostomy products market in EMEA
    • Ostomy products market in APAC
    • Market opportunity
    PART 12: DECISION FRAMEWORK
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/tech1548/global-ostomy-products-market-20182022


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.




    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT2 Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT2 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht2-agonist-pipeline-insight-2018/2086518

    Descriptive coverage of pipeline development activities for “5-HT2 Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT2 Agonist

    The report assesses the active 5-HT2 Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/2086518 

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/2086518

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT2 Agonist

    Features the 5-HT2 Agonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of 5-HT2 Agonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “5-HT2 Agonist

    Discount before buying @ https://www.researchcosmos.com/discount/2086518 

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT2 Agonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence 5-HT2 Agonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “5-HT2 Agonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT2 Agonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT2 Antagonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT2 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht2-antagonist-pipeline-insight-2018/6574367

    Descriptive coverage of pipeline development activities for “5-HT2 Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Request free sample @ https://www.researchcosmos.com/request/6574367

    Pipeline Therapeutics assessment of products for “5-HT2 Antagonist

    The report assesses the active 5-HT2 Antagonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/6574367                                                                                                                                         Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT2 Antagonist
    Features the 5-HT2 Antagonist pipeline across the complete product development cycle including all clinical and non-clinical stages
    Offers detailed therapeutic product profiles of 5-HT2 Antagonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information
    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    Coverage of dormant and discontinued pipeline projects across “5-HT2 Antagonist

    Discount before buying @ https://www.researchcosmos.com/discount/6574367

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT2 Antagonist to formulate effective R&D strategies
    Assess challenges and opportunities that influence 5-HT2 Antagonist research & development (R&D)
    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    Identify and understand the sought after therapy areas and indications for “5-HT2 Antagonist
    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT2 Antagonist to enhance and expand business potential and scope
    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress
    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT2A Agonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT2A Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical

    Non-clinical

    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht2a-agonist-pipeline-insight-2018/6555325

    Descriptive coverage of pipeline development activities for “5-HT2A Agonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT2A Agonist

    The report assesses the active 5-HT2A Agonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/6555325   

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/6555325

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT2A Agonist

    Features the 5-HT2A Agonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of 5-HT2A Agonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “5-HT2A Agonist

    Discount before buying @ https://www.researchcosmos.com/discount/6555325

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT2A Agonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence 5-HT2A Agonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “5-HT2A Agonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT2A Agonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 16, 2018 ) In this report, the EMEA Cardiac Resynchronization Therapy System market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

    Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales K Units, revenue Million USD, market share and growth rate of Cardiac Resynchronization Therapy System for these regions, from 2013 to 2025 forecast

    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/emea-europe-middle-east-and-africa-cardiac-resynchronization-therapy-system-market-8776

    EMEA Cardiac Resynchronization Therapy System market competition by top manufacturers/players, with Cardiac Resynchronization Therapy System sales volume K Units, price USD/Unit, revenue Million USD and market share for each manufacturer/player; the top players including
    Medtronic
    Abbott
    Boston Scientific Corporation
    BIOTRONIK SE & Co. KG
    LivaNova PLC

    On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Cardiac Resynchronization Therapy Pacemaker
    Cardiac Resynchronization Therapy Defibrillator

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals and Clinics
    Diagnostic Centers
    Research Centers and Academic Medical Centers

    Get a Free Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/emea-europe-middle-east-and-africa-cardiac-resynchronization-therapy-system-market-8776
    Table of Contents

    Cardiac Resynchronization Therapy Market Report 2018

    1. Cardiac Resynchronization Therapy Overview
    2 Cardiac Resynchronization Therapy Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    3 Cardiac Resynchronization Therapy Volumes, Value and Sales Price, by Players, Countries, Type and Application
    4 Cardiac Resynchronization Therapy Volumes, Value and Sales Price, by Region, Type and Application
    5 Cardiac Resynchronization Therapy Volumes, Value and Sales Price by Players, Countries, Type and Application
    6 Cardiac Resynchronization Therapy Manufacturers/Players Profiles and Sales Data
    7 Cardiac Resynchronization Therapy Manufacturing Cost Analysis
    8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9 Marketing Strategy Analyses, Distributors/Traders
    10 Market Effect Factors Analysis
    11 Cardiac Resynchronization Therapy Market Forecast 2018-2025
    12 Research Findings and Conclusion
    13 Appendixes
    To Browse Similar Reports @ http://www.planetmarketreports.com/category/medical-devices
    About Us :
    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.
    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.
    Contact Us :
    Name: Ronald James
    Email-Id: ronald.james@planetmarketreports.com
    US : +1-716-2260907
    UK : +447441952057
    Organization: Planet Market Reports




    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) Description:

    This report studies Nitric Oxide Synthase Brain In Global Market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Eli Lilly and Co
    Neurophyxia BV
    ...

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/global-nitric-oxide-synthase-brain-market-10670

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    SBX413
    NXN677
    IC87201
    Others

    By Application, the market can be split into
    Dyskinesia
    Brain Injury
    Migraine
    Musculoskeletal Pain
    Others

    By Regions, this report covers we can add the regions/countries as you want
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

    Get Free Sample of this Report @ https://www.planetmarketreports.com/report-sample/global-nitric-oxide-synthase-brain-market-10670

    Table of Contents

    Global Nitric Oxide Synthase Brain Market Professional Survey Report 2018
    1 Industry Overview of Nitric Oxide Synthase Brain
    1.1 Definition and Specifications of Nitric Oxide Synthase Brain
    1.1.1 Definition of Nitric Oxide Synthase Brain
    1.1.2 Specifications of Nitric Oxide Synthase Brain
    1.2 Classification of Nitric Oxide Synthase Brain
    1.2.1 SBX413
    1.2.2 NXN677
    1.2.3 IC87201
    1.2.4 Others
    1.3 Applications of Nitric Oxide Synthase Brain

    2 Manufacturing Cost Structure Analysis of Nitric Oxide Synthase Brain
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Nitric Oxide Synthase Brain

    3 Technical Data and Manufacturing Plants Analysis of Nitric Oxide Synthase Brain
    3.1 Capacity and Commercial Production Date of Global Nitric Oxide Synthase Brain Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Nitric Oxide Synthase Brain Major Manufacturers in 2017

    4 Global Nitric Oxide Synthase Brain Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis

    5 Nitric Oxide Synthase Brain Regional Market Analysis
    5.1 North America Nitric Oxide Synthase Brain Market Analysis
    5.1.1 North America Nitric Oxide Synthase Brain Market Overview

    Read more…..!!!!!

    To Browse Similar Reports @ https://www.planetmarketreports.com/category/pharmaceutical-and-healthcare

    About Us:-

    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe.  We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

    Contact Us:-

    Name: Ronald James

    Email-Id: ronald.james@planetmarketreports.com

    US: +1-716-2260907

    UK: +447441952057

    Organization: Planet Market Reports

    Website: https://www.planetmarketreports.com/


    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 15, 2018 ) Singapore: A global report titled Central Venous Catheters (CVCs) Market has been introduced into our library of 2.5 million reports.

    About the market report:
    Intravenous access catheters are used to deliver nutrients, fluids, and drugs such as antibiotics, analgesics, and antipyretics, when patient’s body is unable to take in food and nutrition on by own. It is also used for blood transfusion and correction of electrolyte imbalance in patients. These devices use intravenous route of administration that allows rapid delivery of medication and fluids.

    To access the full table of contents of the report click below: https://www.marketintelreports.com/report/tech1523/global-central-venous-catheters-cvcs-market-20172021

    Scope of the Report:
    This report focuses on the Central Venous Catheters Board in global market, especially in Americas, APAC, EMEA. This report categorizes the market based on manufacturers, regions, types and applications.

    Sample companies covered are Teleflex, B. Braun Melsungen, C. R. Bard, Vygon, Cook, Edwards Lifesciences.

    To find out more of the report or request some customization : https://www.marketintelreports.com/inquiry-before-buying.php?id=tech1523

    Table of Contents-Key Points Covered
    PART 01: EXECUTIVE SUMMARY
    PART 02: SCOPE OF THE REPORT
    PART 03: RESEARCH METHODOLOGY
    PART 04: INTRODUCTION
    • Market outline
    • CVCs
    PART 05: MARKET LANDSCAPE
    • Market overview
    ………….
    PART 11: REGIONAL LANDSCAPE
    • Geographical segmentation
    • Regional comparison
    • Americas – market size & forecast
    • EMEA – market size & forecast
    • APAC – market size & forecast
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/tech1523/global-central-venous-catheters-cvcs-market-20172021

    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.




    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 15, 2018 ) “5-HT2B Antagonist - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “5-HT2B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

    Pipeline Products covered across the following Developmental Stages:

    Clinical
    Non-clinical
    Inactive: Discontinued and/or Dormant

    Explore More Information about report @ https://www.researchcosmos.com/reports/5-ht2b-antagonist-pipeline-insight-2018/1828274

    Descriptive coverage of pipeline development activities for “5-HT2B Antagonist - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

    Pipeline Therapeutics assessment of products for “5-HT2B Antagonist

    The report assesses the active 5-HT2B Antagonist pipeline products by developmental stage, product type, molecule type, and administration route.

    Request free sample @ https://www.researchcosmos.com/request/1828274   

    Methodology

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Research Cosmos' team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Inquire before buying @ https://www.researchcosmos.com/inquire/1828274

    Scope of the report

    Provides a snapshot of the therapeutics pipeline activity for “5-HT2B Antagonist

    Features the 5-HT2B Antagonist pipeline across the complete product development cycle including all clinical and non-clinical stages

    Offers detailed therapeutic product profiles of 5-HT2B Antagonist with key coverage of developmental activities including licensing & collaboration deals, patent details, designations, technologies, indications and chemical information

    Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration

    Coverage of dormant and discontinued pipeline projects across “5-HT2B Antagonist

    Discount before buying @ https://www.researchcosmos.com/discount/1828274

    Reasons to Buy

    Establish a comprehensive understanding of the current pipeline scenario across 5-HT2B Antagonist to formulate effective R&D strategies

    Assess challenges and opportunities that influence 5-HT2B Antagonist research & development (R&D)

    Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage

    Identify and understand the sought after therapy areas and indications for “5-HT2B Antagonist

    Identify the product attributes and use it for target finding, drug repurposing, and precision medicine

    Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for 5-HT2B Antagonist to enhance and expand business potential and scope

    Plan prospective mergers and acquisitions effectively by identifying key players in this area and their most promising pipeline therapeutics and developmental progress

    Our extensive domain knowledge on therapy areas supports the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

    About Us:

    Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.


    Dani Rodriguez
    +1 888 709 8757
    dani@researchcosmos.com

    Source: EmailWire.Com

older | 1 | .... | 1034 | 1035 | (Page 1036) | 1037 | 1038 | .... | 1118 | newer